Structures by: Jeong Y. T.
Total: 43
2,4-Bis(4-fluorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19F2NO
Acta Crystallographica Section E (2008) 64, 9 o1710
a=7.6153(3)Å b=21.1392(9)Å c=10.0878(4)Å
α=90.00° β=90.00° γ=90.00°
2,4-Bis(2-chlorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Cl2NO
Acta Crystallographica Section E (2008) 64, 8 o1586
a=7.7070(15)Å b=10.680(2)Å c=11.000(2)Å
α=101.78(3)° β=92.82(3)° γ=98.13(3)°
R-2,c-6-Bis(3-methoxyphenyl)-t-3,t-5-dimethylpiperidin-4-one
C21H25NO3
Acta Crystallographica Section E (2008) 64, 8 o1631
a=20.9885(6)Å b=9.7699(2)Å c=19.8153(5)Å
α=90.00° β=109.459(2)° γ=90.00°
1-Bromoacetyl-2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26BrNO4
Acta Crystallographica Section E (2008) 64, 10 o2009-o2010
a=12.9487(9)Å b=25.2882(18)Å c=8.9701(6)Å
α=90.00° β=132.9300(10)° γ=90.00°
2,4-Bis(3-fluorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19F2NO
Acta Crystallographica Section E (2008) 64, 9 o1708-o1709
a=7.3844(2)Å b=21.5172(10)Å c=10.2608(4)Å
α=90.00° β=90.00° γ=90.00°
N-[4-Acetyl-5-(3-methoxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl]acetamide
C13H15N3O3S
Acta Crystallographica Section E (2008) 64, 11 o2096
a=11.3790(4)Å b=10.5993(3)Å c=11.9596(2)Å
α=90.00° β=108.225(2)° γ=90.00°
2,4-Bis(2-methoxyphenyl)-3-azabicyclo[3.3.1]nonan-9-one
C22H25NO3
Acta Crystallographica Section E (2009) 65, 6 o1383
a=7.8616(2)Å b=20.8443(6)Å c=11.4984(3)Å
α=90.00° β=95.8670(10)° γ=90.00°
2,4-Bis(2-bromophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Br2NO
Acta Crystallographica Section E (2008) 64, 12 o2385
a=7.8389(3)Å b=10.5770(3)Å c=11.0274(3)Å
α=101.099(2)° β=93.725(2)° γ=97.3990(10)°
2,4-Bis(3-bromophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Br2NO
Acta Crystallographica Section E (2008) 64, 12 o2332
a=7.1595(6)Å b=24.5891(19)Å c=10.2598(6)Å
α=90.00° β=90.00° γ=90.00°
2,4-Bis(4-chlorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Cl2NO
Acta Crystallographica Section E (2009) 65, 3 o609
a=16.2589(4)Å b=6.8983(2)Å c=18.1291(5)Å
α=90.00° β=116.1490(10)° γ=90.00°
2,4-Bis(4-chlorophenyl)-1-methyl-3-azabicyclo[3.3.1]nonan-9-one
C21H21Cl2NO
Acta Crystallographica Section E (2010) 66, 3 o545
a=28.4515(14)Å b=7.0380(3)Å c=21.2771(12)Å
α=90.00° β=117.148(4)° γ=90.00°
<i>r</i>-2,<i>c</i>-6-Bis(2-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one acetic acid solvate
C21H25NO3,C2H4O2
Acta Crystallographica Section E (2010) 66, 6 o1428
a=9.3059(5)Å b=10.7052(8)Å c=11.8950(7)Å
α=94.432(3)° β=93.341(2)° γ=109.502(3)°
1-(2-Bromoacetyl)-3-methyl-2,6-diphenylpiperidin-4-one
C20H20BrNO2
Acta Crystallographica Section E (2010) 66, 6 o1479
a=21.4006(8)Å b=14.5873(6)Å c=13.8107(5)Å
α=90.00° β=125.368(2)° γ=90.00°
2,4-Bis(4-propoxyphenyl)-3-azabicyclo[3.3.1]nonan-9-one
C26H33NO3
Acta Crystallographica Section E (2011) 67, 4 o790
a=7.3846(4)Å b=29.3963(19)Å c=10.2739(7)Å
α=90.00° β=90.00° γ=90.00°
2,4-Bis(4-butoxyphenyl)-3-azabicyclo[3.3.1]nonan-9-one
C28H37NO3
Acta Crystallographica Section E (2011) 67, 3 o635
a=7.7780(5)Å b=31.457(2)Å c=9.9560(6)Å
α=90.00° β=90.00° γ=90.00°
1-Chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethylpiperidin-4-one
C21H20Cl3NO2
Acta Crystallographica Section E (2010) 66, 9 o2284
a=11.6295(4)Å b=9.6955(3)Å c=17.4743(5)Å
α=90.00° β=90.4810(10)° γ=90.00°
Ethyl 1-benzoyl-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate
C27H25NO4
Acta Crystallographica Section E (2011) 67, 3 o540
a=8.2784(7)Å b=10.6116(9)Å c=12.7572(11)Å
α=85.681(4)° β=89.963(4)° γ=82.508(5)°
2,4-Bis(3-chlorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Cl2NO
Acta Crystallographica Section E (2009) 65, 4 o840
a=6.9950(14)Å b=12.180(2)Å c=20.770(4)Å
α=90.00° β=90.00° γ=90.00°
2,4-Bis(4-bromophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Br2NO
Acta Crystallographica Section E (2009) 65, 6 o1356
a=6.9415(3)Å b=10.4489(4)Å c=13.2888(5)Å
α=101.542(2)° β=100.391(2)° γ=94.472(2)°
2,4-Bis(2-fluorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19F2NO
Acta Crystallographica Section E (2009) 65, 7 o1596
a=7.4699(3)Å b=10.6621(4)Å c=10.7131(4)Å
α=78.027(2)° β=78.946(2)° γ=87.201(2)°
Ethyl 1-(2-bromopropanoyl)-4-hydroxy-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3- carboxylate
C23H24BrNO4
Acta Crystallographica Section E (2009) 65, 7 o1708-o1709
a=10.3970(4)Å b=14.4874(6)Å c=15.8580(7)Å
α=65.457(2)° β=89.556(3)° γ=80.597(3)°
1-Chloroacetyl-2,6-bis(3-fluorophenyl)piperidin-4-one
C19H16ClF2NO2
Acta Crystallographica Section E (2009) 65, 8 o1994-o1995
a=10.7026(8)Å b=8.2017(6)Å c=19.0447(15)Å
α=90.00° β=100.6290(10)° γ=90.00°
1-Chloroacetyl-2,6-bis(2-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26ClNO4
Acta Crystallographica Section E (2009) 65, 9 o2276-o2277
a=8.9921(6)Å b=11.3725(8)Å c=11.9373(8)Å
α=71.6300(10)° β=68.4650(10)° γ=72.9030(10)°
1-Methyl-2,4-bis(2-methoxyphenyl)-3-azabicyclo[3.3.1]nonan-9-one
C23H27NO3
Acta Crystallographica Section E (2009) 65, 12 o3103
a=7.9569(3)Å b=20.8291(9)Å c=11.6708(6)Å
α=90.00° β=96.297(2)° γ=90.00°
Ethyl 4-hydroxy-2,6-diphenyl-1-(2-thiomorpholinopropanoyl)- 1,2,5,6-tetrahydropyridine-3-carboxylate
C27H32N2O4S
Acta Crystallographica Section E (2009) 65, 12 o3180-o3181
a=9.904(3)Å b=11.400(4)Å c=12.103(4)Å
α=93.908(18)° β=104.941(15)° γ=106.819(16)°
Ethyl 4-hydroxy-1-(2-morpholinopropanoyl)-2,6-diphenyl- 1,2,5,6-tetrahydropyridin-3-carboxylate
C27H32N2O5
Acta Crystallographica Section E (2009) 65, 12 o3232-o3233
a=8.2251(2)Å b=10.6219(4)Å c=28.7046(10)Å
α=90.00° β=92.375(2)° γ=90.00°
2,4-Bis(3-methoxyphenyl)-3-azabicyclo[3.3.1]nonan-9-one
C22H25NO3
Acta Crystallographica Section E (2010) 66, 1 o48-o49
a=22.3843(9)Å b=6.5666(3)Å c=13.0745(4)Å
α=90.00° β=106.382(2)° γ=90.00°
2,4-Bis(2-fluorophenyl)-1-methyl-3-azabicyclo[3.3.1]nonan-9-one
C21H21F2NO
Acta Crystallographica Section E (2010) 66, 1 o194-o195
a=7.8481(3)Å b=10.5417(4)Å c=10.9333(4)Å
α=76.196(2)° β=80.026(2)° γ=86.014(2)°
Ethyl 4-(3-chlorophenyl)-3,6-dihydroxy-6-methyl-2-(2-pyridyl)-4,5,6,7- tetrahydroindazole-5-carboxylate
C22H22ClN3O4
Acta Crystallographica Section E (2010) 66, 4 o861
a=8.585(5)Å b=9.053(3)Å c=14.884(3)Å
α=94.68(2)° β=90.19(2)° γ=115.66(3)°
2,6-Bis(3-fluorophenyl)-3-isopropylpiperidin-4-one
C20H21F2NO
Acta Crystallographica Section E (2010) 66, 7 o1860
a=8.8217(3)Å b=12.7612(4)Å c=30.8613(9)Å
α=90.00° β=91.892(2)° γ=90.00°
Ethyl 4-hydroxy-2,6-diphenyl-1-(2-thiomorpholinoacetyl)-1,2,5,6-tetrahydropyridine- 3-carboxylate
C26H30N2O4S
Acta Crystallographica Section E (2010) 66, 8 o1982
a=10.9561(6)Å b=9.5665(6)Å c=22.9011(12)Å
α=90.00° β=93.575(3)° γ=90.00°
Ethyl 4-hydroxy-2,6-diphenyl-1-[2-(piperidin-1-yl)acetyl]-1,2,5,6- tetrahydropyridine-3-carboxylate
C27H32N2O4
Acta Crystallographica Section E (2010) 66, 8 o2005
a=10.7936(6)Å b=9.6752(6)Å c=23.2335(13)Å
α=90.00° β=93.213(3)° γ=90.00°
2,4-Bis(2-methylphenyl)-3-azabicyclo[3.3.1]nonan-9-one <i>O</i>-methyloxime
C23H28N2O
Acta Crystallographica Section E (2010) 66, 11 o2978
a=6.9700(9)Å b=15.3476(16)Å c=18.354(2)Å
α=90.00° β=94.622(4)° γ=90.00°
Ethyl 4-[2-(3,5-dimethyl-4-oxo-2,6-diphenylpiperidin-1- yl)-2-oxoethyl]piperazine-1-carboxylate
C28H35N3O4
Acta Crystallographica Section E (2011) 67, 3 o541
a=10.9073(3)Å b=19.1940(6)Å c=12.2246(3)Å
α=90.00° β=91.809(2)° γ=90.00°
Dimethyl 2-(3-chlorophenyl)-6-hydroxy-6-methyl-4-(methylamino)cyclohex-3-ene- 1,3-dicarboxylate
C18H22ClNO5
Acta Crystallographica Section E (2011) 67, 6 o1424
a=11.962(3)Å b=9.118(4)Å c=17.704(5)Å
α=90.00° β=104.890(3)° γ=90.00°
2,4-Bis(2-ethoxyphenyl)-7-methyl-3-azabicyclo[3.3.1]nonan-9-one
C25H31NO3
Acta Crystallographica Section E (2011) 67, 6 o1475-o1476
a=10.3147(6)Å b=11.8817(6)Å c=18.7809(10)Å
α=90.00° β=100.866(2)° γ=90.00°
Ethyl 1-[2-(1<i>H</i>-benzotriazol-1-yl)acetyl]-4-hydroxy-2,6-diphenyl- 1,2,5,6-tetrahydropyridine-3-carboxylate
C28H26N4O4
Acta Crystallographica Section E (2011) 67, 7 o1574
a=7.9214(2)Å b=21.9667(6)Å c=14.5621(4)Å
α=90.00° β=95.722(2)° γ=90.00°
Ethyl 1-[2-(1,3-benzoxazol-2-ylsulfanyl)acetyl]-4-hydroxy-2,6-diphenyl- 1,2,5,6-tetrahydropyridine-3-carboxylate
C29H26N2O5S
Acta Crystallographica Section E (2011) 67, 7 o1731
a=12.4630(2)Å b=24.3243(5)Å c=9.2350(2)Å
α=90.00° β=109.6080(10)° γ=90.00°
1-(3,5-Dichlorophenyl)-1<i>H</i>-1,2,3,4-tetrazole
C7H4Cl2N4
Acta Crystallographica Section E (2012) 68, 2 o433
a=3.8362(2)Å b=9.0524(3)Å c=24.8876(11)Å
α=90.00° β=91.956(4)° γ=90.00°
1-(4-Methylphenyl)-1<i>H</i>-1,2,3,4-tetrazole
C8H8N4
Acta Crystallographica Section E (2012) 68, 2 o394
a=9.8352(13)Å b=5.7244(6)Å c=14.4190(19)Å
α=90.00° β=96.285(12)° γ=90.00°
1-(4-Chlorophenyl)-1<i>H</i>-1,2,3,4-tetrazole
C7H5ClN4
Acta Crystallographica Section E (2012) 68, 5 o1344
a=3.8626(2)Å b=27.9946(10)Å c=14.4943(5)Å
α=90.00° β=95.640(3)° γ=90.00°
(<i>E</i>)-Ethyl 2-cyano-3-(furan-2-yl)acrylate
C10H9NO3
Acta Crystallographica Section E (2012) 68, 5 o1482
a=4.6611(2)Å b=19.8907(9)Å c=20.9081(9)Å
α=90.00° β=91.988(4)° γ=90.00°
(<i>Z</i>)-Ethyl 2-cyano-3-(1<i>H</i>-imidazol-2-yl)acrylate
C9H9N3O2
Acta Crystallographica Section E (2013) 69, 8 o1223
a=10.0768(7)Å b=12.0387(8)Å c=7.7047(6)Å
α=90.00° β=90.00° γ=90.00°